Hanmi Pharm. Co., Ltd. Logo

Hanmi Pharm. Co., Ltd.

Biopharma firm developing innovative diabetes and cancer drugs for patients and professionals.

128940 | KO

Overview

Corporate Details

ISIN(s):
KR7128940004
LEI:
Country:
South Korea
Address:
경기도 화성시 팔탄면 무하로 214, 화성시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Hanmi Pharmaceutical Co., Ltd., established in 1973, is a leading South Korean biopharmaceutical company with a strong focus on research and development. The company develops, manufactures, and markets a broad portfolio of in-house medicines, including prescription drugs, over-the-counter (OTC) products, medical supplies, and raw materials. Hanmi is recognized for its innovative drug development, particularly in the therapeutic areas of diabetes and cancer, and is committed to providing advanced medical solutions to healthcare professionals and patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-16 00:00
Report Publication Announcement
기업설명회(IR)개최(안내공시)
Korean 6.1 KB
2025-09-03 00:00
Regulatory News Service
[기재정정]투자판단관련주요경영사항
Korean 13.3 KB
2025-09-01 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 46.4 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 3.4 MB
2025-08-14 00:00
Interim Report
[기재정정]반기보고서 (2025.06)
Korean 3.5 MB
2025-08-01 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 59.1 KB
2025-08-01 00:00
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
Korean 31.0 KB
2025-07-28 00:00
Report Publication Announcement
기업설명회(IR)개최(안내공시)
Korean 6.0 KB
2025-07-25 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.5 KB
2025-07-25 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 92.2 KB
2025-07-18 00:00
Report Publication Announcement
결산실적공시예고(안내공시)
Korean 4.4 KB
2025-07-18 00:00
Report Publication Announcement
기업설명회(IR)개최(안내공시)
Korean 6.1 KB
2025-07-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 53.2 KB
2025-07-01 00:00
Report Publication Announcement
기업설명회(IR)개최(안내공시)
Korean 6.1 KB
2025-06-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 72.8 KB

Automate Your Workflow. Get a real-time feed of all Hanmi Pharm. Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Hanmi Pharm. Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Hanmi Pharm. Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Prestige Consumer Healthcare Inc. Logo
Develops and markets leading over-the-counter brands for personal healthcare and wellness.
United States of America
PBH
Processa Pharmaceuticals, Inc. Logo
Develops next-gen chemo and therapies for chronic and life-threatening diseases.
United States of America
PCSA
Develops protein-based immunotherapies for metabolic diseases, immune disorders, and cancer.
South Korea
296160
PROKIDNEY CORP. Logo
Develops cellular therapies to preserve kidney function for patients with advanced Chronic Kidney Disease.
United States of America
PROK
ProMIS Neurosciences Inc. Logo
Developing selective antibody therapies targeting toxic proteins in neurodegenerative diseases.
United States of America
PMN
Propanc Biopharma, Inc. Logo
Developing proenzyme therapies to prevent solid tumor recurrence and metastasis.
United States of America
PPCB
ProQR Therapeutics N.V. Logo
Biotech developing RNA-editing therapies for genetic disorders using the body's own enzymes.
United States of America
PRQR
Protagenic Therapeutics, Inc.\new Logo
Developing novel peptide drugs to treat stress-related neuropsychiatric & CNS disorders.
United States of America
PTIX
Protagonist Therapeutics, Inc Logo
Develops peptide therapeutics for blood disorders and inflammatory or immunomodulatory diseases.
United States of America
PTGX
Protalix BioTherapeutics, Inc. Logo
Develops plant-cell-based protein therapies for rare diseases like Gaucher and Fabry.
United States of America
PLX

Talk to a Data Expert

Have a question? We'll get back to you promptly.